Skip to content

Clinical trials

Completed Hypersensitivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Status: Completed Country / region: Canada Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20059
20062
20073
20083
20094
20102
20112
20123
20131
20146
20154
20161
20173
20186
20191
20213
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergy Therapeutics10
Circassia Limited7
Aimmune Therapeutics, Inc.3
AstraZeneca3
Novartis Pharmaceuticals3
University of British Columbia3
ALK-Abelló A/S2
Celgene2
McMaster University2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity59
Hypersensitivity, Immediate19
Asthma11
Immune System Diseases8
Rhinitis, Allergic, Seasonal8
Rhinitis6
Dermatitis, Atopic4
Eczema4
Genetic Diseases, Inborn4
Rhinitis, Allergic4

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.